Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner

References

• Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324: 84–8
   PubMed Web of Science ®Google Scholar
• Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996; 38: 738–41
   PubMed Web of Science ®Google Scholar
• Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 1988; 29: 990–6
   PubMed Web of Science ®Google Scholar
• Thompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus environment in inflammatory bowel disease: results of a British twin study. Br Med J 1996; 312: 95–6
   PubMed Web of Science ®Google Scholar
• Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263–74
   PubMed Web of Science ®Google Scholar
• Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995–1003
   PubMed Web of Science ®Google Scholar
• Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999; 30: 526–30
   PubMed Web of Science ®Google Scholar
• Suarez A, Castro P, Alonso R, Mozo L, Gutierrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003; 75: 711–71
   PubMed Web of Science ®Google Scholar
• Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, McMahon R, Whorwell PJ, et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999; 54: 386–90
   PubMedGoogle Scholar
• Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 2000; 1: 185–90
   PubMed Web of Science ®Google Scholar
• Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, et al. The IL-10 gene is not involved in the predisposition to inflammatory disease. Electrophoresis 2000; 21: 3578–82
   PubMed Web of Science ®Google Scholar
• Aithal GP, Craggs A, Day CP, Aithal GP, Craggs A, Day CP, et al. Role of polymorphisms in the Interleukin-10 gene in determining disease susceptibility and phenotype in inflammatory bowel disease. Dig Dis Sci 2001; 46: 1520–5
   PubMed Web of Science ®Google Scholar
• Celik Y, Dagli U, Kilic MY, Toruner M, Ozen SC, Ozkan M, et al. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol 2006; 41: 559–65
   PubMed Web of Science ®Google Scholar
• Castro-Santos P, Suarez A, Lòpez-Rivas L, Mozo L, Gutierrez C. TNF-alpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of –1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol 2006; 101: 1039–47
   PubMed Web of Science ®Google Scholar
• Rozen SS, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365–86
   PubMedGoogle Scholar
• Zhou L, Wang L, Palais R, Pryor R, Wittwer CT. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 2005; 51: 1770–7
   PubMed Web of Science ®Google Scholar
• Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online 2005; 1: 47–50
   PubMed Web of Science ®Google Scholar
• Sham PC, Curtis D. Monte Carlo test for associations between disease and alleles at highly polymorphic loci. Ann Hum Gen 1995; 59: 97–105
   PubMed Web of Science ®Google Scholar
• Huibregtse IL, van Lent AU, van Deventer SJ. Immunopathogenesis of IBD: insufficient suppressor function in the gut?. Gut 2007; 56: 584–92
   PubMed Web of Science ®Google Scholar
• Mendoza JL, Urcelay E, Lana R, Martinez A, Taxonera C, de la Concha EG, et al. Polymorphisms in the interleukin-10 gene and relation to phenotype in patients with ulcerative colitis. Rev Esp Enferm Apar Dig 2006; 98: 93–100
   Google Scholar
• Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005; 100: 1134–42
   PubMed Web of Science ®Google Scholar
• Friedrichs F, Brescianini S, Annese V, Latiano A, Berger K, Kugathasan S, et al. Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet 2006; 119: 305–11
   PubMed Web of Science ®Google Scholar
• Biank V, Friedrichs F, Babusukumar U, Wang T, Stoll M, Broeckel U, et al. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease. Am J Gastroenterol 2007; 102: 391–8
   PubMed Web of Science ®Google Scholar
• Paladino N, Fainboim H, Theiler G, Schroder T, Munoz AE, et al. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol 2006; 80: 9144–50
   PubMed Web of Science ®Google Scholar
• Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, et al. Gender-specific association between (1082 IL-10 promoter polymorphism and longevity. Gen Immun 2002; 3: 30–3
   PubMed Web of Science ®Google Scholar
• Carruba G, D'Agostino P, Miele M, Calabrò M, Barbera C, Bella GD, et al. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J Cell Biochem 2003; 90: 187–96
   PubMed Web of Science ®Google Scholar
• Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1352–5
   PubMed Web of Science ®Google Scholar
• Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 754–9
   PubMed Web of Science ®Google Scholar